{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:21:22Z","timestamp":1793308882271,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s12026-023-09429-6","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T18:02:24Z","timestamp":1698256944000},"page":"242-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rational design of multi-epitope-based vaccine by exploring all dengue virus serotypes proteome: an immunoinformatic approach"],"prefix":"10.1007","volume":"72","author":[{"given":"Ahad Amer","family":"Alsaiari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ageeli","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader S.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia S.","family":"Alkhalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hazazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Alkhorayef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-615X","authenticated-orcid":false,"given":"Khurshid","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"Yasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"issue":"1","key":"9429_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-09199-w","volume":"7","author":"M Ali","year":"2017","unstructured":"Ali M, et al. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection. Sci Rep. 2017;7(1):1\u201313.","journal-title":"Sci Rep."},{"issue":"1","key":"9429_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1567-1348(03)00004-2","volume":"3","author":"EC Holmes","year":"2003","unstructured":"Holmes EC, Twiddy SS. The origin, emergence and evolutionary genetics of dengue virus. Infect Genet Evol. 2003;3(1):19\u201328.","journal-title":"Infect Genet Evol."},{"issue":"4","key":"9429_CR3","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/jme\/tjy010","volume":"55","author":"MU Mukhtar","year":"2018","unstructured":"Mukhtar MU, et al. Seasonal distribution and container preference ratio of the dengue fever vector (Aedes aegypti, Diptera: Culicidae) in Rawalpindi, Pakistan. J Med Entomol. 2018;55(4):1011\u20135.","journal-title":"J Med Entomol."},{"issue":"22","key":"9429_CR4","doi-asserted-by":"publisher","first-page":"13911","DOI":"10.3390\/ijms232213911","volume":"23","author":"M Mukhtar","year":"2022","unstructured":"Mukhtar M, Wajeeha AW, Bibi N. Engineering Modified mRNA-Based Vaccine against Dengue Virus Using Computational and Reverse Vaccinology Approaches. Int J Mol Sci. 2022;23(22):13911.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"9429_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/17460441.2020.1811675","volume":"16","author":"F Idris","year":"2021","unstructured":"Idris F, Ting DHR, Alonso S. An update on dengue vaccine development, challenges, and future perspectives. Expert Opin Drug Discovery. 2021;16(1):47\u201358.","journal-title":"Expert Opin Drug Discovery."},{"issue":"10","key":"9429_CR6","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.4049\/jimmunol.1700029","volume":"198","author":"T Hertz","year":"2017","unstructured":"Hertz T, et al. Antibody epitopes identified in critical regions of dengue virus nonstructural 1 protein in mouse vaccination and natural human infections. J Immunol. 2017;198(10):4025\u201335.","journal-title":"J Immunol."},{"issue":"16","key":"9429_CR7","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00018-010-0357-z","volume":"67","author":"IA Rodenhuis-Zybert","year":"2010","unstructured":"Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci. 2010;67(16):2773\u201386.","journal-title":"Cell Mol Life Sci."},{"issue":"2","key":"9429_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3201\/eid0102.952004","volume":"1","author":"DJ Gubler","year":"1995","unstructured":"Gubler DJ, Clark GG. Dengue\/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis. 1995;1(2):55.","journal-title":"Emerg Infect Dis."},{"issue":"1","key":"9429_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.humimm.2021.09.006","volume":"83","author":"R Thomas","year":"2022","unstructured":"Thomas R, et al. Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand. Hum Immunol. 2022;83(1):53\u201360.","journal-title":"Hum Immunol."},{"issue":"11","key":"9429_CR10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2174\/1381612823666170913163904","volume":"24","author":"K Reginald","year":"2018","unstructured":"Reginald K, et al. Development of peptide vaccines in dengue. Curr Pharm Des. 2018;24(11):1157\u201373.","journal-title":"Curr Pharm Des."},{"issue":"1","key":"9429_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinf. 2007;8(1):1\u20137.","journal-title":"BMC Bioinf."},{"issue":"W1","key":"9429_CR12","doi-asserted-by":"publisher","first-page":"W502","DOI":"10.1093\/nar\/gkz452","volume":"47","author":"SK Dhanda","year":"2019","unstructured":"Dhanda SK, et al. IEDB-AR: immune epitope database\u2014analysis resource in 2019. Nucleic Acids Res. 2019;47(W1):W502\u20136.","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"9429_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-03988-0","volume":"12","author":"K Jalal","year":"2022","unstructured":"Jalal K, et al. Identification of vaccine and drug targets in Shigella dysenteriae sd197 using reverse vaccinology approach. Sci Rep. 2022;12(1):1\u201319.","journal-title":"Sci Rep."},{"issue":"1","key":"9429_CR14","doi-asserted-by":"publisher","first-page":"120139","DOI":"10.1098\/rsob.120139","volume":"3","author":"A Patronov","year":"2013","unstructured":"Patronov A, Doytchinova I. T-cell epitope vaccine design by immunoinformatics. Open biology. 2013;3(1):120139.","journal-title":"Open biology"},{"issue":"8","key":"9429_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.6026\/97320630010480","volume":"10","author":"AR Tanu","year":"2014","unstructured":"Tanu AR, et al. Identification and validation of T-cell epitopes in outer membrane protein (OMP) of Salmonella typhi. Bioinformation. 2014;10(8):480.","journal-title":"Bioinformation"},{"issue":"1","key":"9429_CR16","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1038\/s41598-019-41496-4","volume":"9","author":"V Solanki","year":"2019","unstructured":"Solanki V, Tiwari M, Tiwari V. Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa. Sci Rep. 2019;9(1):5240.","journal-title":"Sci Rep."},{"issue":"1","key":"9429_CR17","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1038\/s41598-018-26689-7","volume":"8","author":"V Solanki","year":"2018","unstructured":"Solanki V, Tiwari V. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii. Sci Rep. 2018;8(1):9044.","journal-title":"Sci Rep."},{"issue":"9","key":"9429_CR18","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta S, et al. In silico approach for predicting toxicity of peptides and proteins. PloS one. 2013;8(9):e73957.","journal-title":"PloS one"},{"key":"9429_CR19","doi-asserted-by":"publisher","unstructured":"Jalal K, Khan K, Uddin R. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300. Immunol Res. 2023;71(2):247\u201366. https:\/\/doi.org\/10.1007\/s12026-022-09346-0.","DOI":"10.1007\/s12026-022-09346-0"},{"issue":"6","key":"9429_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.pt.2019.04.002","volume":"35","author":"LS Hohman","year":"2019","unstructured":"Hohman LS, Peters NC. CD4+ T cell-mediated immunity against the phagosomal pathogen Leishmania: Implications for vaccination. Trends Parasitol. 2019;35(6):423\u201335.","journal-title":"Trends Parasitol."},{"key":"9429_CR21","doi-asserted-by":"publisher","first-page":"131920","DOI":"10.1016\/j.molstruc.2021.131920","volume":"1250","author":"R Uddin","year":"2022","unstructured":"Uddin R, Jalal K, Khan K. Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors. J Mol Struct. 2022;1250:131920.","journal-title":"J Mol Struct."},{"issue":"6843","key":"9429_CR22","first-page":"190","volume":"412","author":"K Pethe","year":"2001","unstructured":"Pethe K, et al. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nat Methods. 2001;412(6843):190\u20134.","journal-title":"Nat Methods."},{"issue":"3","key":"9429_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/21645515.2015.1012017","volume":"11","author":"Y Yang","year":"2015","unstructured":"Yang Y, et al. In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations. Hum Vaccin Immunother. 2015;11(3):795\u2013805.","journal-title":"Hum Vaccin Immunother."},{"issue":"11","key":"9429_CR24","doi-asserted-by":"publisher","first-page":"e0142563","DOI":"10.1371\/journal.pone.0142563","volume":"10","author":"H Ghaffari-Nazari","year":"2015","unstructured":"Ghaffari-Nazari H, et al. Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB\/c mice. PloS one. 2015;10(11):e0142563.","journal-title":"PloS one"},{"issue":"23","key":"9429_CR25","doi-asserted-by":"publisher","first-page":"12814","DOI":"10.3390\/ijms222312814","volume":"22","author":"K Jalal","year":"2021","unstructured":"Jalal K, et al. Pan-genome reverse vaccinology approach for the design of multi-epitope vaccine construct against Escherichia albertii. Int J Mol Sci. 2021;22(23):12814.","journal-title":"Int J Mol Sci."},{"key":"9429_CR26","doi-asserted-by":"publisher","unstructured":"Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, Hochstrasser DF. Protein identification and analysis tools in the ExPASy server. Methods Mol Biol. 1999;112:531\u201352. https:\/\/doi.org\/10.1385\/1-59259-584-7:531.\u00a0","DOI":"10.1385\/1-59259-584-7:531"},{"issue":"1","key":"9429_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"J Yang","year":"2015","unstructured":"Yang J, et al. The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2015;12(1):7\u20138.","journal-title":"Nat Methods."},{"issue":"suppl_2","key":"9429_CR28","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007;35(suppl_2):W407\u201310.","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"9429_CR29","doi-asserted-by":"publisher","first-page":"W402","DOI":"10.1093\/nar\/gkz297","volume":"47","author":"DW Buchan","year":"2019","unstructured":"Buchan DW, Jones DT. The PSIPRED protein analysis workbench: 20 years on. Nucleic Acids Res. 2019;47(W1):W402\u20137.","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"9429_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, et al. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst. 1993;26(2):283\u201391.","journal-title":"J Appl Cryst."},{"key":"9429_CR31","doi-asserted-by":"publisher","unstructured":"Jalal K, Khan K, Basharat Z, Abbas MN, Uddin R, Ali F, Khan SA, Hassan SSU. Reverse vaccinology approach for multi-epitope centered vaccine design against delta variant of the SARS-CoV-2. Environ Sci Pollut Res Int. 2022;29(40):60035\u201353. https:\/\/doi.org\/10.1007\/s11356-022-19979-1.\u00a0","DOI":"10.1007\/s11356-022-19979-1"},{"issue":"suppl_2","key":"9429_CR32","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gki481","volume":"33","author":"D Schneidman-Duhovny","year":"2005","unstructured":"Schneidman-Duhovny D, et al. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 2005;33(suppl_2):W363\u20137.","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"9429_CR33","doi-asserted-by":"publisher","first-page":"e10033","DOI":"10.1371\/journal.pone.0010033","volume":"5","author":"C March","year":"2010","unstructured":"March C, et al. Dissection of host cell signal transduction during Acinetobacter baumannii\u2013triggered inflammatory response. PloS one. 2010;5(4):e10033.","journal-title":"PloS one"},{"issue":"W1","key":"9429_CR34","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","volume":"47","author":"G Weng","year":"2019","unstructured":"Weng G, et al. HawkDock: a web server to predict and analyze the protein\u2013protein complex based on computational docking and MM\/GBSA. Nucleic Acids Res. 2019;47(W1):W322\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"9429_CR35","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605\u201312.","journal-title":"J Comput Chem."},{"issue":"1","key":"9429_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/nar\/29.1.221","volume":"29","author":"RA Laskowski","year":"2001","unstructured":"Laskowski RA. PDBsum: summaries and analyses of PDB structures. Nucleic Acids Res. 2001;29(1):221\u20132.","journal-title":"Nucleic Acids Res."},{"key":"9429_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19\u201325.","journal-title":"SoftwareX"},{"key":"9429_CR38","doi-asserted-by":"crossref","unstructured":"Tahir ul Qamar, M., et al., Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2. Infect Dis Poverty., 2020. 9(1). 1-14.","DOI":"10.1186\/s40249-020-00752-w"},{"issue":"suppl_2","key":"9429_CR39","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote A, et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 2005;33(suppl_2):W526\u201331.","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"9429_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1473-3099(16)00026-8","volume":"16","author":"JD Stanaway","year":"2016","unstructured":"Stanaway JD, et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(6):712\u201323.","journal-title":"Lancet Infect Dis."},{"issue":"9","key":"9429_CR41","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s41564-019-0476-8","volume":"4","author":"JP Messina","year":"2019","unstructured":"Messina JP, et al. The current and future global distribution and population at risk of dengue. Nat Microbiol. 2019;4(9):1508\u201315.","journal-title":"Nat Microbiol."},{"key":"9429_CR42","first-page":"169","volume":"34","author":"MJ Tahir","year":"2020","unstructured":"Tahir MJ, et al. Devastating urban flooding and dengue outbreak during the COVID-19 pandemic in Pakistan. Med J Islam Repub Iran. 2020;34:169.","journal-title":"Med J Islam Repub Iran."},{"issue":"4","key":"9429_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20151960","volume":"213","author":"R Rappuoli","year":"2016","unstructured":"Rappuoli R, et al. Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design. J Exp Med. 2016;213(4):469\u201381.","journal-title":"J Exp Med."},{"issue":"9","key":"9429_CR44","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4161\/hv.6.9.12739","volume":"6","author":"B Guy","year":"2010","unstructured":"Guy B, Saville M, Lang J. Development of Sanofi Pasteur tetravalent dengue vaccine. Hum Vaccin. 2010;6(9):696\u2013705.","journal-title":"Hum Vaccin."},{"issue":"5","key":"9429_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/vaccines10050665","volume":"10","author":"TH Albekairi","year":"2022","unstructured":"Albekairi TH, et al. Designing of a Novel Multi-Antigenic Epitope-Based Vaccine against E. hormaechei: An Intergraded Reverse Vaccinology and Immunoinformatics Approach. Vaccines. 2022;10(5):665.","journal-title":"Vaccines"},{"key":"9429_CR46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.molimm.2019.09.018","volume":"116","author":"M Nosrati","year":"2019","unstructured":"Nosrati M, et al. Designing a multi-epitope vaccine for cross-protection against Shigella spp: an immunoinformatics and structural vaccinology study. Mol Immunol. 2019;116:106\u201316.","journal-title":"Mol Immunol."},{"key":"9429_CR47","doi-asserted-by":"crossref","unstructured":"Tosta, S.F.d.O., et al., Multi-epitope based vaccine against yellow fever virus applying immunoinformatics approaches. Journal of Biomolecular Structure Dynamics, 2021. 39(1): 219-235.","DOI":"10.1080\/07391102.2019.1707120"},{"issue":"3","key":"9429_CR48","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/imm.12327","volume":"143","author":"CJ Reynolds","year":"2014","unstructured":"Reynolds CJ, et al. The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles. Immunology. 2014;143(3):438\u201346.","journal-title":"Immunology"},{"issue":"5","key":"9429_CR49","doi-asserted-by":"publisher","first-page":"151508","DOI":"10.1016\/j.ijmm.2021.151508","volume":"311","author":"J Li","year":"2021","unstructured":"Li J, et al. Reverse vaccinology approach for the identifications of potential vaccine candidates against Salmonella. Int J Med Microbiol. 2021;311(5):151508.","journal-title":"Int J Med Microbiol."},{"issue":"1","key":"9429_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-8-86","volume":"8","author":"FA Bozza","year":"2008","unstructured":"Bozza FA, et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis. 2008;8(1):1\u201311.","journal-title":"BMC Infect Dis."},{"issue":"1","key":"9429_CR51","first-page":"25","volume":"123","author":"A Chakravarti","year":"2006","unstructured":"Chakravarti A, Kumaria R. Circulating levels of tumour necrosis factor-[alpha] & interferon-[gamma] in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian J Med Res. 2006;123(1):25.","journal-title":"Indian J Med Res."},{"issue":"4","key":"9429_CR52","first-page":"658","volume":"21","author":"I Kurane","year":"1990","unstructured":"Kurane I, et al. Human immune responses to dengue viruses. Southeast Asian J Trop Med Public Health. 1990;21(4):658\u201362.","journal-title":"Southeast Asian J Trop Med Public Health."},{"key":"9429_CR53","doi-asserted-by":"crossref","unstructured":"ul Qamar, M.T., et al., Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches. Comput Biol Med., 2021. 132: . 104389.","DOI":"10.1016\/j.compbiomed.2021.104389"},{"issue":"1","key":"9429_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80899-6","volume":"11","author":"S Bibi","year":"2021","unstructured":"Bibi S, et al. In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology. Sci Rep. 2021;11(1):1\u201316.","journal-title":"Sci Rep"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-023-09429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-023-09429-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-023-09429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T08:18:08Z","timestamp":1713514688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-023-09429-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["9429"],"URL":"https:\/\/doi.org\/10.1007\/s12026-023-09429-6","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants and animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}